Matters of the heart: assessing the cardiovascular safety of new drugs
- PMID: 14564304
- DOI: 10.1016/S0002-8703(03)00400-9
Matters of the heart: assessing the cardiovascular safety of new drugs
Comment on
-
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.Am Heart J. 2003 Oct;146(4):591-604. doi: 10.1016/S0002-8703(03)00398-3. Am Heart J. 2003. PMID: 14564311 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
